BridgeBio Pharma (BBIO) EBT Margin (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,840.00 |
| Dec 31, 2025 | 2,818.00 |
| Sep 30, 2025 | 980.00 |
| Jun 30, 2025 | -6,389.00 |
| Mar 31, 2025 | 442,588.00 |
| Dec 31, 2024 | 148,594.00 |
| Sep 30, 2024 | -252,772.00 |
| Jun 30, 2024 | -347,548.00 |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | -675,069.00 |
| Sep 30, 2023 | 562,469.00 |
| Jun 30, 2023 | -209,920.00 |
| Mar 31, 2023 | -2,277.00 |
| Dec 31, 2022 | 3.56 Mn |
| Sep 30, 2022 | -4.32 Mn |
| Jun 30, 2022 | 1.13 Mn |
| Mar 31, 2022 | -963,206.00 |
| Dec 31, 2021 | 503,444.00 |
| Sep 30, 2021 | -561,033.00 |
| Jun 30, 2021 | 3.70 Mn |
| Mar 31, 2021 | 7.48 Mn |
| Dec 31, 2020 | -11.15 Mn |